- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Swiss Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
3
0 new
High return on equity, past performance and sound balance sheet.
3 companies
Novartis
Market Cap: CHF 172.1b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN
CHF 90.68
7D
0.5%
1Y
2.0%
SKAN Group
Market Cap: CHF 1.4b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 62.20
7D
-1.7%
1Y
-23.7%
Cosmo Pharmaceuticals
Market Cap: CHF 734.3m
Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.
COPN
CHF 45.85
7D
-5.1%
1Y
-38.4%